• Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Oragenics Inc

+ Add to Watchlist

OGEN:US

1.9501 USD 0.0101 0.52%

As of 20:04:03 ET on 07/11/2014.

Snapshot for Oragenics Inc (OGEN)

Open: 1.9000 Day's Range: 1.9000 - 1.9800 Volume: 7,055
Previous Close: 1.9400 52wk Range: 1.5600 - 4.6500 1-Yr Rtn: -38.09%

Stock Chart for OGEN

No chart data available.
  • OGEN:US 1.9501
  • 1D
  • 1M
  • 1Y
1.9400
Interactive OGEN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OGEN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5640
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 70.46
Shares Outstanding (M) 36.13
30 Day Average Volume 24,751
Price/Book (mrq) 4.9605
Price/Sale (ttm) 56.4143
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OGEN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OGEN

Oragenics, Inc. is a biotechnology research and development company seeking to commercialize technologies based on different strains of bacterias. The Company's technologies include a replacement therapy for tooth cavity protection and a new broad-spectrum antibiotic.

John N BonfiglioPresident/CEOMichael O Sullivan "Mike"CFO/Treasurer/Secretary
Martin HandfieldVP:Research & Development
More Company Profile & Key Executives for OGEN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil